Published :
Tables : 51
Figures : 45
Category : Healthcare
No. of Pages : 230
Report Code : HC-1182
Flow Cytometry Market is poised to value at a CAGR of over 8.2% during the forecast period 2022 to 2028. FutureWise Market Research has instantiated a report that provides an intricate analysis of Flow Cytometry Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market According to the research study conducted by FutureWise research analysts, the Flow Cytometry Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Flow cytometry deals with the detection of the physicochemical properties of a cell or particle. The working of flow cytometry is based on the principle of light scattering. The use of flow cytometry technique at laboratory levels has shown notable growth since the past few years resulting in the market growth. Flow cytometry has eased the analysis of complex structures and is less time-consuming. Hence the preference by research institutes towards the adoption of flow cytometry techniques is rising. The soaring incidences and prevalence of HIV/ AIDS and cancer, increased availability of application-specific products are the major factors contributing to the growth of the market. In developing countries, the adoption of advanced research and development has gained popularity. The investments and funds provided are favourable to boost the market in such emerging countries. The applications of the flow cytometry technique in hematology has recorded notable results. One of the best examples is its use in the detection and quantification of fetal red cells in maternal blood. Furthermore, the leucocyte analysis for immunological monitoring of HIV/AIDS patients is made easy by flow cytometry. Most private and public organizations tend to invest in such projects which results in the growth of the market size. The reagents and consumables market is estimated to increase the market growth. The demand for reagents and consumables for flow cytometry is high across the globe irrespective of region. Since the instrumentation is expensive, the purchase of advanced instruments by end-users is relatively low, which is affecting the market. As the flow cytometry is more popular for research purpose, the research institutes spend more budget on flow cytometry techniques and hence are estimated to hold a large market share. North America is estimated to be the global leader in this market. The funds provided by private and public organizations for research in flow cytometry are favourable to market growth. Furthermore, Europe and the Asia Pacific are the dominating regions for the flow cytometry market owing to soaring demand for clinical research products and new advancements. Major players included in the Flow Cytometry Market: • Becton, Dickinson and Company • Beckman Coulter (A Subsidiary of Danaher) • Thermo Fisher Scientific • Merck KGaA • Luminex Corporation • Agilent Technologies • Sony Biotechnology (A Subsidiary of Sony Corporation of America) • Cytonome/St, LLC Laboratories • Miltenyi Biotec • Enzo Life Sciences, Inc. (A Subsidiary of Enzo Biochem) • Sysmex Partec (A Subsidiary of Sysmex Corporation) • Biomérieux SA • Cytonome/St, LLC • Stratedigm, Inc. • Apogee Flow Systems • Cytek Biosciences, Inc. • Sartorius AG • Union Biometrica, Inc. • Nanocellect Biomedical, Inc. • On-Chip Biotechnologies Co., Ltd. (Note: The list of the major players will be updated with the latest market scenario and trends) Flow Cytometry Market Segmentation: By Technology • Cell-based Flow Cytometry • Bead-based Flow Cytometry By Product and Service • Reagents and Consumables • Instruments o Cell Analyzers o High-range o Mid-range o Low-range o Cell Sorters o High-range o Mid-range o Low-range • Services • Software • Accessories By Application • Research Applications o Pharmaceuticals and Biotechnology o Drug Discovery o Stem Cell Research o In Vitro Toxicity Testing o Immunology o Cell Sorting o Apoptosis o Cell Cycle Analysis o Cell Viability o Cell Counting o Other Research Applications • Clinical Applications o Cancer Diagnostics o Hematology o Immunodeficiency Diseases o Organ Transplantation o Other Clinical Applications • Industrial Applications By End User • Academic & Research Institutes • Hospitals & Clinical Testing Laboratories • Pharmaceutical & Biotechnology Companies By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Flow Cytometry Market By Technology, By Product and Service, By Application, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- Mode of operation launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
FutureWise Market Research has instantiated a report that provides an intricate analysis of Flow Cytometry Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market
According to the research study conducted by FutureWise research analysts, the Flow Cytometry Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Flow cytometry deals with the detection of the physicochemical properties of a cell or particle. The working of flow cytometry is based on the principle of light scattering. The use of flow cytometry technique at laboratory levels has shown notable growth since the past few years resulting in the market growth.
Flow cytometry has eased the analysis of complex structures and is less time-consuming. Hence the preference by research institutes towards the adoption of flow cytometry techniques is rising.
The soaring incidences and prevalence of HIV/ AIDS and cancer, increased availability of application-specific products are the major factors contributing to the growth of the market.
In developing countries, the adoption of advanced research and development has gained popularity. The investments and funds provided are favourable to boost the market in such emerging countries.
The applications of the flow cytometry technique in hematology has recorded notable results. One of the best examples is its use in the detection and quantification of fetal red cells in maternal blood. Furthermore, the leucocyte analysis for immunological monitoring of HIV/AIDS patients is made easy by flow cytometry. Most private and public organizations tend to invest in such projects which results in the growth of the market size.
The reagents and consumables market is estimated to increase the market growth. The demand for reagents and consumables for flow cytometry is high across the globe irrespective of region. Since the instrumentation is expensive, the purchase of advanced instruments by end-users is relatively low, which is affecting the market.
As the flow cytometry is more popular for research purpose, the research institutes spend more budget on flow cytometry techniques and hence are estimated to hold a large market share.
North America is estimated to be the global leader in this market. The funds provided by private and public organizations for research in flow cytometry are favourable to market growth. Furthermore, Europe and the Asia Pacific are the dominating regions for the flow cytometry market owing to soaring demand for clinical research products and new advancements.
Major players included in the Flow Cytometry Market: • Becton, Dickinson and Company • Beckman Coulter (A Subsidiary of Danaher) • Thermo Fisher Scientific • Merck KGaA • Luminex Corporation • Agilent Technologies • Sony Biotechnology (A Subsidiary of Sony Corporation of America) • Cytonome/St, LLC Laboratories • Miltenyi Biotec • Enzo Life Sciences, Inc. (A Subsidiary of Enzo Biochem) • Sysmex Partec (A Subsidiary of Sysmex Corporation) • Biomérieux SA • Cytonome/St, LLC • Stratedigm, Inc. • Apogee Flow Systems • Cytek Biosciences, Inc. • Sartorius AG • Union Biometrica, Inc. • Nanocellect Biomedical, Inc. • On-Chip Biotechnologies Co., Ltd. (Note: The list of the major players will be updated with the latest market scenario and trends)
Flow Cytometry Market Segmentation: By Technology • Cell-based Flow Cytometry • Bead-based Flow Cytometry By Product and Service • Reagents and Consumables • Instruments o Cell Analyzers o High-range o Mid-range o Low-range o Cell Sorters o High-range o Mid-range o Low-range • Services • Software • Accessories By Application • Research Applications o Pharmaceuticals and Biotechnology o Drug Discovery o Stem Cell Research o In Vitro Toxicity Testing o Immunology o Cell Sorting o Apoptosis o Cell Cycle Analysis o Cell Viability o Cell Counting o Other Research Applications • Clinical Applications o Cancer Diagnostics o Hematology o Immunodeficiency Diseases o Organ Transplantation o Other Clinical Applications • Industrial Applications By End User • Academic & Research Institutes • Hospitals & Clinical Testing Laboratories • Pharmaceutical & Biotechnology Companies By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the Flow Cytometry Market By Technology, By Product and Service, By Application, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- Mode of operation launches, technological advancements, mergers and expansions
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Flow Cytometry Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Flow Cytometry Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Flow Cytometry Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Flow Cytometry Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Cell-based Flow Cytometry 7.2. Bead-based Flow Cytometry 8. Flow Cytometry Market, By Product and Service Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Reagents and Consumables 8.2. Instruments 8.2.1. Cell Analyzers 8.2.1.1. High-range 8.2.1.2. Mid-range 8.2.1.3. Low-range 8.2.2. Cell Sorters 8.2.2.1. High-range 8.2.2.2. Mid-range 8.2.2.3. Low-range 8.3. Services 8.4. Software 8.5. Accessories 9. Flow Cytometry Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Research Applications 9.1.1. Pharmaceuticals and Biotechnology 9.1.1.1. Drug Discovery 9.1.1.2. Stem Cell Research 9.1.1.3. In Vitro Toxicity Testing 9.1.2. Immunology 9.1.3. Cell Sorting 9.1.4. Apoptosis 9.1.5. Cell Cycle Analysis 9.1.6. Cell Viability 9.1.7. Cell Counting 9.1.8. Other Research Applications 9.2. Clinical Applications 9.2.1. Cancer Diagnostics 9.2.2. Hematology 9.2.3. Immunodeficiency Diseases 9.2.4. Organ Transplantation 9.2.5. Other Clinical Applications 9.3. Industrial Applications 10. Flow Cytometry Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Academic & Research Institutes 10.2. Hospitals & Clinical Testing Laboratories 10.3. Pharmaceutical & Biotechnology Companies 11. North America Flow Cytometry Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028 12. Latin America Flow Cytometry Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028 13. Europe Flow Cytometry Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028 14. Asia Pacific Flow Cytometry Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028 16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Becton, Dickinson and Company 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Beckman Coulter (A Subsidiary of Danaher) 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Thermo Fisher Scientific 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Merck KGaA 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Luminex Corporation 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Agilent Technologies 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Sony Biotechnology (A Subsidiary of Sony Corporation of America) 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Cytonome/St, LLC Laboratories 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Miltenyi Biotec 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Enzo Life Sciences, Inc. (A Subsidiary of Enzo Biochem). 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11.Sysmex Partec (A Subsidiary of Sysmex Corporation) 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12.Biomérieux SA 17.12.1. Company Overview 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview 17.13.Cytonome/St, LLC 17.13.1. Company Overview 17.13.2. Product Portfolio 17.13.3. SWOT Analysis 17.13.4. Financial Overview 17.13.5. Strategic Overview 17.14.Stratedigm, Inc. 17.14.1. Company Overview 17.14.2. Product Portfolio 17.14.3. SWOT Analysis 17.14.4. Financial Overview 17.14.5. Strategic Overview 17.15.Apogee Flow Systems 17.15.1. Company Overview 17.15.2. Product Portfolio 17.15.3. SWOT Analysis 17.15.4. Financial Overview 17.15.5. Strategic Overview 17.16.Cytek Biosciences, Inc. 17.16.1. Company Overview 17.16.2. Product Portfolio 17.16.3. SWOT Analysis 17.16.4. Financial Overview 17.16.5. Strategic Overview 17.17.Sartorius AG 17.17.1. Company Overview 17.17.2. Product Portfolio 17.17.3. SWOT Analysis 17.17.4. Financial Overview 17.17.5. Strategic Overview 17.18.Union Biometrica, Inc. 17.18.1. Company Overview 17.18.2. Product Portfolio 17.18.3. SWOT Analysis 17.18.4. Financial Overview 17.18.5. Strategic Overview 17.19.Nanocellect Biomedical, Inc. 17.19.1. Company Overview 17.19.2. Product Portfolio 17.19.3. SWOT Analysis 17.19.4. Financial Overview 17.19.5. Strategic Overview 17.20.On-Chip Biotechnologies Co., Ltd. 17.20.1. Company Overview 17.20.2. Product Portfolio 17.20.3. SWOT Analysis 17.20.4. Financial Overview 17.20.5. Strategic Overview 18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Flow Cytometry Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Flow Cytometry Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Flow Cytometry Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Flow Cytometry Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Cell-based Flow Cytometry 7.2. Bead-based Flow Cytometry
8. Flow Cytometry Market, By Product and Service Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Reagents and Consumables 8.2. Instruments 8.2.1. Cell Analyzers 8.2.1.1. High-range 8.2.1.2. Mid-range 8.2.1.3. Low-range 8.2.2. Cell Sorters 8.2.2.1. High-range 8.2.2.2. Mid-range 8.2.2.3. Low-range 8.3. Services 8.4. Software 8.5. Accessories
9. Flow Cytometry Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Research Applications 9.1.1. Pharmaceuticals and Biotechnology 9.1.1.1. Drug Discovery 9.1.1.2. Stem Cell Research 9.1.1.3. In Vitro Toxicity Testing 9.1.2. Immunology 9.1.3. Cell Sorting 9.1.4. Apoptosis 9.1.5. Cell Cycle Analysis 9.1.6. Cell Viability 9.1.7. Cell Counting 9.1.8. Other Research Applications 9.2. Clinical Applications 9.2.1. Cancer Diagnostics 9.2.2. Hematology 9.2.3. Immunodeficiency Diseases 9.2.4. Organ Transplantation 9.2.5. Other Clinical Applications 9.3. Industrial Applications
10. Flow Cytometry Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Academic & Research Institutes 10.2. Hospitals & Clinical Testing Laboratories 10.3. Pharmaceutical & Biotechnology Companies
11. North America Flow Cytometry Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028
12. Latin America Flow Cytometry Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028
13. Europe Flow Cytometry Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028
14. Asia Pacific Flow Cytometry Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028
16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Becton, Dickinson and Company 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Beckman Coulter (A Subsidiary of Danaher) 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Thermo Fisher Scientific 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Merck KGaA 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Luminex Corporation 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Agilent Technologies 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Sony Biotechnology (A Subsidiary of Sony Corporation of America) 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Cytonome/St, LLC Laboratories 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Miltenyi Biotec 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Enzo Life Sciences, Inc. (A Subsidiary of Enzo Biochem). 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11.Sysmex Partec (A Subsidiary of Sysmex Corporation) 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12.Biomérieux SA 17.12.1. Company Overview 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview 17.13.Cytonome/St, LLC 17.13.1. Company Overview 17.13.2. Product Portfolio 17.13.3. SWOT Analysis 17.13.4. Financial Overview 17.13.5. Strategic Overview 17.14.Stratedigm, Inc. 17.14.1. Company Overview 17.14.2. Product Portfolio 17.14.3. SWOT Analysis 17.14.4. Financial Overview 17.14.5. Strategic Overview 17.15.Apogee Flow Systems 17.15.1. Company Overview 17.15.2. Product Portfolio 17.15.3. SWOT Analysis 17.15.4. Financial Overview 17.15.5. Strategic Overview 17.16.Cytek Biosciences, Inc. 17.16.1. Company Overview 17.16.2. Product Portfolio 17.16.3. SWOT Analysis 17.16.4. Financial Overview 17.16.5. Strategic Overview 17.17.Sartorius AG 17.17.1. Company Overview 17.17.2. Product Portfolio 17.17.3. SWOT Analysis 17.17.4. Financial Overview 17.17.5. Strategic Overview 17.18.Union Biometrica, Inc. 17.18.1. Company Overview 17.18.2. Product Portfolio 17.18.3. SWOT Analysis 17.18.4. Financial Overview 17.18.5. Strategic Overview 17.19.Nanocellect Biomedical, Inc. 17.19.1. Company Overview 17.19.2. Product Portfolio 17.19.3. SWOT Analysis 17.19.4. Financial Overview 17.19.5. Strategic Overview 17.20.On-Chip Biotechnologies Co., Ltd. 17.20.1. Company Overview 17.20.2. Product Portfolio 17.20.3. SWOT Analysis 17.20.4. Financial Overview 17.20.5. Strategic Overview
18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics